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Abstract 25 
Borosilicate bioactive glasses (BBGs) have shown capacity to improve the new bone 26 
formation when compared to silicate bioactive glasses. Herein, we assessed the capacity 27 
of BBGs to induce the osteogenic differentiation of bone marrow mesenchymal stem 28 
cells (BM-MSCs), as a function of their substituted divalent cations (Mg2+, Ca2+, Sr2+). 29 
To this purpose, we synthesized BBG particles by melt quench. The cell viability, 30 
proliferation and morphology, (i.e. PrestoBlue®, PicroGreen®, and DAPI and Phalloidin 31 
stainings, respectively) as well as protein expression (of ALP, osteopontin and 32 
osteocalcin) of BM-MSCs in contact with the BBGs were evaluated for 21 days. We 33 
observed an enhanced expression of bone-specific proteins (ALP, OP and OC) and high 34 
mineralization of BM-MSCs under BBG-Mg and BBG±Sr conditioned osteogenic 35 
media for concentrations of 20 and 50 mg/ml with low cytotoxic effects. Moreover, 36 
BBG-Sr at a concentration of 50 mg/ml was able to increase the mineralization and 37 
expression of bone-specific proteins even under basal media conditions. These results 38 
indicated that the proposed BBGs improved the osteogenic differentiation of BM-39 
MSCs. Therefore, showing their potential as relevant biomaterials for bone tissue 40 
regeneration, not only by bonding to bone tissue, but also by stimulating new bone 41 
formation. 42 
 43 
Key words: Borosilicate glasses, strontium, mineralization, osteogenic induction, BM-44 
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1. Introduction 47 
The properties of bioactive glasses (BGs) support their key relevance of in clinical 48 
applications associated to bone tissue repair and regeneration.(1, 2) They are part of a 49 
tissue engineering-based strategy that can overcome the drawbacks of the traditionally 50 
used autologous bone grafts (e.g. lack of adequate amount and quality of bone, donor 51 
site morbidity). BGs are considered relevant for bone tissue repair since they: (i) 52 
promote osteointegration (forming a bone-like hydroxyapatite (HA) layer on their 53 
surface); (ii) are biocompatible; and (iii) their degradation shows positive biological 54 
effects after implantation.(2-5) There are however drawbacks associated with 55 
conventional BGs including in vitro cytotoxicity related to the release of Na+ ions, and 56 
interest in modified compositions has increased in recent years.(6) 57 
Recently, borosilicate bioactive glasses (BBGs) have attracted interest in bone tissue 58 
engineering.(1, 7, 8) BBGs have shown capability to improve the new bone formation 59 
when compared to silicate-based BGs.(9, 10) They present controllable degradation 60 
rates and have a high compositional flexibility that potentially allows BBGs to be 61 
tailored with enhanced osteogenic and angiogenic properties, as well as with 62 
antibacterial capacity.(11, 12) On one hand, as shown by Huang et al., a glass network 63 
composed of ERURVLOLFDWH¶V have more controllable conversion rates to HA.(13) This has 64 
also been demonstrated to occur in vivo.(14) As a matter of fact, the addition of borate 65 
to the glass network can also be beneficial for bone healing, as well as formation, and 66 
maintenance of new bone, while supporting cell osteogenic differentiation.(15) 67 
Frequently, it has been associated with the increase in bone resistance to fracture.(16, 68 
17) On the other hand, by exploiting the compositional flexibility of BBGs, inorganic 69 
divalent cations, such as Mg2+, Ca2+ and Sr2+ can be incorporated and play a key role in 70 
bone metabolism. For instance, Mg2+ increases bone formation rate as well as stimulates 71 
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bone cell adhesion increasing their stability.(18, 19) The Ca2+ is known to be essential 72 
during the apatite formation process, being also favorable to osteoblast proliferation, 73 
differentiation and the mineralization of the extracellular matrix (ECM).(20) Sr2+ also 74 
has bone therapeutic potential. Different studies evidenced its beneficial effects on bone 75 
cells and bone formation in vivo,(21, 22) being even used for the treatment of 76 
osteoporosis.(23) 77 
BGs are known to be osteoinductive materials, capable of stimulating the function and 78 
osteogenic differentiation of bone and stem cells without any additional 79 
supplementation. Findings from Fu et al. suggested that the borosilicate 13-93B1 80 
scaffolds supported the proliferation and function of osteogenic Murine Osteocyte-like 81 
Cell Line MLO-A5,(15) while Gentleman et al. demonstrated that Sr2+-substituted 82 
bioactive glasses stimulated osteoblast metabolic activity promoting cell proliferation 83 
and ALP activity.(24) More significantly, Santocildes et al. demonstrated that Sr-84 
containing BGs appeared to be capable of promoting osteoblastic differentiation in a 85 
proportion of bone marrow mesenchymal stem cells (BM-MSCs) that were in some way 86 
pre-committed to this lineage.(25) Liang et al. showed that borate glasses support the 87 
attachment and differentiation of human bone marrow derived mesenchymal stem cells 88 
and human mesenchymal stem cell derived osteoblasts.(26) 89 
The present study aims to fabricate three substituted BBGs to be used in bone tissue 90 
repair and regeneration field. The incorporation of different divalent cations (i.e. Mg2+, 91 
Ca2+, Sr2+) into the BBGs was tested due to the fact that the release of these cations 92 
might induce specific effects on BM-MSCs, such as: in their proliferation, 93 
differentiation and the mineralization of the ECM, as well as stimulating bone cells and 94 
promoting bone formation.(11) BM-MSCs are a cell type of especial interest for bone 95 
tissue research and therapy because of their ease and reproducibility of isolation as well 96 
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as their ability to differentiate into mesodermal lineage cells such as osteoblasts, 97 
osteoclasts and osteocytes.(27) Therefore, we aimed to investigate the effects of BBGs 98 
biological activity over viability, proliferation, and differentiation of BM-MSCs, 99 
providing novel biocompatible BBGs that promote osteointegration and cell 100 
differentiation for bone tissue engineering. 101 
2. Experimental 102 
2.1. Preparation of BBGs 103 
The BBGs of general formula 0.05Na2O  xMgO  yCaO  (0.35-x-y)SrO  0.20B2O3  104 
0.40SiO2 (molar ratio, where x, y = 0.35 or 0.00, and x y) were synthesized by melt-105 
quenching. The suitable amounts of, silica (SiO2, Macherey-Nagel, Germany), boron 106 
oxide (B2O3, Alfa Aesar, Germany), sodium bicarbonate (NaHCO3, Sigma-Aldrich, 107 
Australia), and magnesium oxide (MgO, Sigma-Aldrich, Portugal), or calcium 108 
carbonate (CaCO3, Sigma-Aldrich, Portugal), or strontium carbonate (SrCO3, Sigma-109 
Aldrich, Portugal) were thoroughly mixed with the addition of ethanol in a porcelain 110 
pestle with the help of a mortar, vacuum dried overnight and transferred to a platinum 111 
crucible. After entirely dried, each batch was heaWHG WR  Û& LQ DLU IRU  K and 112 
subsequently the melt was quickly poured into cold water to form the glass frit. 113 
Afterwards, the as-quenched glasses were ground in an Agate mortar (RETSCH, 114 
Germany) and sieved to a particle size <63 ȝP %HIRUH WKH in vitro tests BBG-Mg 115 
(0.05Na2O  0.35MgO  0.20B2O3  0.40SiO2), BBG-Ca (0.05Na2O  0.35CaO  116 
0.20B2O3  0.40SiO2) or BBG-Sr (0.05Na2O  0.35SrO  0.20B2O3  0.40SiO2) were 117 
weighted, dried and sterilized at 160 ºC for at least 2 h. 118 
 6 
2.2. Morphology and chemical composition of BBGs 119 
The morphology of the synthesized BBGs was observed by scanning electron 120 
microscopy (SEM, model S360, Leica Cambridge, UK) equipped with energy 121 
dispersive X-ray spectroscopy (SEM/EDS link-eXL-II) for the determination of the 122 
surface chemical composition. 123 
2.3. Isolation and expansion of mesenchymal stem cells 124 
Bone marrow mesenchymal stem cells (BM-MSCs) were isolated from bone marrow of 125 
4-5 week-old male Wistar rats according to the method established by Maniatopoulos et 126 
al. (28) and recently proposed by Santocildes et al..(25) BM-MSCs were expanded in 127 
basal medium FRQVLVWLQJ RI 'XOEHFFR¶V PRGLILHG (DJOH¶V PHGLXP 'MEM; Sigma-128 
Aldrich, UK), supplemented with 100 U/ml penicillin (Sigma,-Aldrich, UK) and 1 129 
mg/ml streptomycin (Sigma-Aldrich, UK). Cells were cultured at 37 ºC in an 130 
atmosphere of 5% CO2. 131 
Prior to the in vitro studies, BM-MSCs, at passage 2, were harvested and seeded into 24 132 
well plates, at a density of 2×104 cells per well. Cells were cultured in the presence of 133 
the BBGs at concentrations of 20 and 50 mg/ml, for 7, 14 and 21 days under static 134 
conditions. The BM-MSCs cultured in the absence of BBGs were used as negative 135 
control and in the presence of 45S5 bioglass® as positive control. The BBGs at the 136 
desired concentrations and 45S5 bioglass® were deposited on top of the cells, in cell 137 
culture inserts with porous membranes (0.4 µm 7KLQ&HUWV &HOO &XOWXUH ,QVHUWV138 
Greiner, Germany), as used in previous works (29). 7KH7KLQ&HUWVZHUHXVHGDVDn 139 
inert platform to support the glass particles under cell culture conditions. All conditions 140 
were cultured in basal and osteogenic differentiation media (basal medium 141 
supplemented with 50 µg/ml ascorbic acid, 10 mM ȕ-glycerophosphate and 10-8 M 142 
dexamethasone). Figure 1 presents a schematic of the experimental design. 143 
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Figure 1. Schematic of the experimental design. 144 
2.4. Potential cytotoxic effect of BBGs dissolution on BM-MSCs 145 
Cell viability and proliferation (PrestoBlue® and PicoGreen® assays). The 146 
PrestoBlue® reagent (Fisher Scientific, UK) is a resazurin-based solution that is reduced 147 
to resorufin by viable cells which can be detected fluorimetrically.  The cell viability 148 
assay was executed DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV ,Q EULHI WKH149 
PrestoBlue® reagent was added to a final concentration of 10% to the wells and the cells 150 
were incubated for 1 h at 37 oC. Afterwards, 200 µl samples of the culture medium were 151 
removed and placed in 96-well plates and the resorufin fluorescence was quantified 152 
spectrophotometrically using a plate reader (Tecan Infinite M200). The fluorescence 153 
was determined at an excitation wavelength of 560 nm and emission wavelength of 590 154 
nm. The metabolic activity was presented in fluorescence values and compared with the 155 
control (cell cultured in the absence of glass particles under basal medium conditions). 156 
The PicoGreen® dsDNA reagent (Invitrogen, USA) is an ultrasensitive fluorescent 157 
nucleic acid dye for quantification of double-stranded DNA (dsDNA) in solution. This 158 
assay enables the measurement of cell proliferation. After each culturing period, the cell 159 
monolayers were washed with PBS and then incubated at 37 ºC for 3 h followed by a 160 
freezing step at -80 ºC for at least over night in ultra-pure water (1 ml) to ensure cell 161 
lysis. The assay was performed according tR WKH PDQXIDFWXUHU¶V SURWRFRO And the 162 
fluorescence was determined at an excitation wavelength of 485 nm and emission 163 
wavelength of 528 nm. The DNA concentration was presented in µg/ml and compared 164 
with the control (cell cultured in the absence of glass particles under basal medium 165 
conditions). 166 
 8 
Cell morphology and distribution. After each culturing period the cell grown in tissue 167 
culture coverslips were washed with PBS and fixed with 4% formalin solution (0.5 ml) 168 
for 15 min at room temperature (RT). The cell layers were then washed with PBS, 169 
containing 0.2% Triton X, for 2 min. After the fixation and permeation steps, the cell 170 
monolayers were washed again with PBS and stained with 4,6-diamidino-2-phenyindole 171 
dilactate (1:1000 DAPI, Sigma, UK) for 2 min at RT, and phalloidin-172 
tetramethylrhodamine B isothiocyanate (Sigma, UK) for 1 h at RT. Finally, the cells 173 
were washed and observed using an Axioplan 2 imaging fluorescent microscope with a 174 
digital camera QIC AM 12-bit (Zeiss, UK). 175 
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2.5. Osteogenic capacity of BBGs on BM-MSCs 176 
Alkaline phosphatase quantification. The concentration of alkaline phosphatase 177 
(ALP) was determined for all the culture time periods, using the lysates used for DNA 178 
quantification. Briefly, the ALP quantity was assessed using the Alkaline Phosphatase, 179 
Diethanolamine Detection kit (Sigma-Aldrich, UK) in which p-nitrophenyl phosphatase 180 
(pNPP) solution is hydrolyzed by ALP to yellow free p-nitrophenol. In brief, a buffered 181 
pNPP solution was prepared and equilibrated at 37 ºC. Afterwards, 2% (v/v) of sample 182 
or control were added. Immediately after mixing the absorbance was read at 405 nm in a 183 
plate reader (Tecan Infinite M200) for § 5 min. An ALP standard solution was used as 184 
control and buffer as blank. The units were calculated according to the following 185 
equation: ሺ ?࡭૝૙૞࢔࢓Ȁ ܕܑܖ ࢀࢋ࢙࢚ି ?࡭૝૙૞࢔࢓Ȁ ܕܑܖ ࡮࢒ࢇ࢔࢑ሻൈࢊࢌൈࢂࡲ૚ૡǤ૞ൈࢂࡱ . Where df = dilution factor; VF = 186 
Volume of final solution; 18.5 = millimolar extinction coefficient of pNPP at 405 nm 187 
and VE = Volume of samples/ALP standard solution. ALP activity was calculated by 188 
normalizing ALP concentration per DNA concentration for each condition and time 189 
point. 190 
Alizarin red staining. After 21 days culture, the cells grown in tissue culture coverslips 191 
were fixed in 70% ice-cold methanol at -20 °C at least for 30 min. The cell layers were 192 
then washed with PBS and dried overnight. Afterwards, cells were stained with alizarin 193 
red solution for 10 min [342 mg of alizarin red, (Sigma-Aldrich, UK) in 25 ml of 194 
distilled water and the pH was adjusted to 4.1 with 10% ammonium hydroxide (Sigma-195 
Aldrich, UK)] for 10 min. The coverslips were then, washed in distilled water, 196 
dehydrated in acetone/xylene (Sigma-Aldrich, UK) solution and mounted using an 197 
aqueous mountant. The stained constructs were observed under an optical microscope 198 
(BX51, Olympus Corporation, UK) and images captured by a digital camera (DP70, 199 
Olympus Corporation, UK). The BM-MSCs morphology and mineral deposition was 200 
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also observed using SEM (model S360, Leica Cambridge, England) equipped with 201 
energy dispersive X-ray spectroscopy (SEM/EDS link-eXL-II) for the determination of 202 
the surface chemical composition. 203 
Immunodetection of bone-specific proteins. Osteopontin (OP) and osteocalcin (OC) 204 
protein expression of BM-MSCs was assessed by immunoassay technique to evaluate 205 
their osteoblastic differentiation. The procedures were executed according to the 206 
PDQXIDFWXUHU¶VLQVWUXFWLRQVThe concentrations of OP and OC were determined for all 207 
the culture time periods, using the lysates used for DNA quantification. The OP 208 
quantitative determination was performed using Mouse/Rat Osteopontin Quantikine 209 
ELISA Kit (R&D Systems, UK). In brief, 50 µl of assay diluent RD1W and 50 µl of 210 
standard (2500 to 39 pg/ml), control and samples were added and the plate incubated for 211 
2 h at RT. After 4 washing steps and perfectly dried, 100 µl of Mouse/Rat OP 212 
Conjugated were added and incubated for 2 h at RT. The sandwich complex was 213 
washed 4 times and allowed to react with 100 µl of substrate solution before adding 100 214 
µl of stop solution. Finally, the optical density was determined at 450 nm and the 215 
concentration of OP obtained from a standard curve plot. OC quantitative determination 216 
was performed by the use of Rat Gla-Osteocalcin High Sensitive EIA kit (Takara 217 
Clontech, Japan). In brief, 100 µl of samples and standard solution (16 to 0.25 ng/ml) 218 
were incubated for 1 h at 37 ºC with the capture-antibody, rat osteocalcin C-terminus-219 
specific antibody. After OC capture and 3 washing steps, 100 µl of the enzyme-labelled 220 
antibody (GlaOC4-30) specific to Gla-OC was incubated for 1 h at RT. The sandwich 221 
complex was washed 4 times and allowed to react with 100 µl of substrate solution for 222 
10-15 min. Finally, after adding the stop solution the optical density was determined at 223 
450 nm and the concentration of OC obtained from a standard curve plot. OP and OC 224 
11 
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content was calculated by normalizing OP or OC concentration per DNA concentration 225 
for each condition and time point. 226 
2.6. Statistical analysis 227 
Results are expressed as mean ± standard deviation with n = 3 for each sample. Error 228 
bars represent standard deviations. The data was analyzed by non-parametric statistics: 229 
Kruskal-Wallis test (p IROORZHG E\ D 'XQQ¶V 0XOWLSOH &RPSDULVRQ WHVW *** 230 
p<0.001; ** p<0.01; * p<0.05 in respect to the control. 231 
3. Results and discussion 232 
3.1 Morphology of BBGs and their chemical composition 233 
BBGs¶ frits were successfully obtained by melt quenching and ground in a controlled 234 
manner. Figure 2a, 2b and 2c show the SEM/EDS analysis of BBGs, which exhibited an 235 
angular shape with low sphericity and confirmed the successful incorporation of the 236 
different modifier divalent cations (i.e. Mg2+, Ca2+ and Sr2+). The composition of BBGs 237 
was confirmed in a prior work by the use of X-ray fluorescence and follows the general 238 
formula 0.05Na2OxMgOyCaO(0.35-x-y)SrO0.20B2O30.40SiO2 (molar ratio, where x, 239 
y = 0.35 or 0.00, and x y). (30) Moreover, studies after immersion in SBF, showed that 240 
the studied BBGs are bioactive due to the formation of bone-like apatite structures onto 241 
their surface, and the constant release of ions to the reaction media over time. (29) 242 
 243 
Figure 2. SEM/EDS micrographs of BBGs, a) BBG-Mg, b) BBG-Ca and c) BBG-Sr. 244 
SEM images are shown as insets, displaying the morphology of the glass particles. The 245 
specific modifier divalent cation is highlighted in yellow for each BBG. 246 
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3.2 In Vitro biological evaluation 247 
Osteoblast differentiation can be divided into three stages: cell proliferation, ECM 248 
synthesis and maturation, and ECM mineralization, each with a cellular characteristic 249 
behavior.(31) 250 
3.2.1 Potential cytotoxic effect of BBGs leachables on BM-MSCs 251 
The effect of BBGs¶ concentration on cell viability and proliferation was studied on a 252 
previous work (29, 30). It showed that a concentration between 20 and 50 mg/ml did not 253 
significantly affect cell viability and proliferation. On the other hand, Romero et al. (32) 254 
studied the osteogenic response of BM-MSCs to strontium-substituted bioactive glasses 255 
(SrBG) and observed that 20 mg of Sr50BG promoted the osteoblastic differentiation of 256 
BM-MSCs. Based on these results, we decided on the BBGs concentrations of 20 and 257 
50 mg/ml. 258 
Herein, we cultured BM-MSCs in basal and osteogenic differentiation media for 7, 14 259 
and 21 days under static conditions, in the presence and absence of BBGs, in order to 260 
evaluate their biological activity and capacity to maintain their structural integrity. The 261 
cellular metabolism and proliferation was evaluated by quantifying the conversion of 262 
resazurin-to resorufin by viable cells; the amount of double stranded DNA (live cells) in 263 
the culture wells; and their morphology. The data was analyzed in comparison with the 264 
BM-MSCs (without any BBGs, i.e. control experiment) to evaluate the impact of BBGs 265 
in the cell behavior. 266 
Fluorescence microscopy images showed the morphology of BM-MSCs in culture 267 
containing BBGs or 45S5 bioglass® (Figure 3). The adhered BM-MSCs exhibited a 268 
well-spread morphology, exhibiting cell-to-cell contacts in a comparable manner on the 269 
BBGs conditioned cultures as in the control experiment. While BM-MSCs cultured with 270 
13 
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45S5 bioglass® presented a round shape for the last time point (21 days), suggesting cell 271 
death. At the same timepoint, especially for cultures under osteogenic differentiation 272 
media (e.g. BBG-Sr), there was distinguishable well-spread polygonal shape cells, 273 
suggesting osteoblast-like morphology. 274 
 275 
 Figure 3. BM-MSCs morphology observed by fluorescence microscopy, after 7, 14 276 
and 21 days culture with BBGs either under basal or osteogenic culture medium.  Each 277 
sample was incubated at two different concentrations (20 and 50 mg/ml). Cells cultured 278 
with basal and osteo medium were used as negative control and 45S5 bioglass® 279 
incubated with medium was used as positive control. Nuclei stained blue by DAPI; 280 
Actin stained green by Phalloidin. 281 
 282 
Figure 4. Metabolic activity (PrestoBlue® assay) and proliferation (PicoGreen® assay) 283 
of BM-MSCs cultured either in basal or osteogenic media in the presence of different 284 
concentrations (20 and 50 mg/ml) of BBG-Mg (a, b), BBG-Ca (c, d) and BBG-Sr (e, f). 285 
The 45S5 bioglass® (g, h) was used as control. Standard culture medium was used as 286 
negative control. Results are expressed as mean ± standard deviation with n = 3 for each 287 
bar. The data was analyzed by non-parametric statistics: Kruskal-Wallis test (p<0.0001), 288 
IROORZHG E\ D 'XQQ¶V 0XOWLSOH &RPSDULVRQ WHVW *** p<0.001; ** p<0.01; * p<0.05 in 289 
respect to the control. The statistical significance is represented relative to the control of 290 
BM-MSCs culture in basal media for the respective day of culture (i.e. 7, 14 and 21 291 
days). 292 
 293 
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From the PrestoBlue® data (Figure 4a, 4c, 4e and 4g) it is possible to observe that the 294 
metabolic activity of BM-MSCs increased over the 21 days of culture. In the first 7 days 295 
of culture, the BM-MSCs under conditioned cultures presented reduced viability in 296 
respect to the cells culture under basal condition (negative control), especially for BBG-297 
Ca culture conditions, which may be due to the initial burst release of ions to the media. 298 
In contrast, from day 14, BM-MSC cultures under osteogenic media displayed a 299 
reduction of metabolic activity with respect to the control (absence of glass particles and 300 
cell cultured under basal medium). It is noteworthy that BM-MSC cultures at day 21 301 
with 45S5 bioglass® under osteogenic media showed very low metabolic activity when 302 
compared with the control experiment (osteogenic media), being consistent with the cell 303 
death observed by fluorescent microscopy (Figure 3). Complementary to the viability 304 
analysis, the cellular proliferation was also assessed by measuring the total cell DNA 305 
(Figure 4b, 4d, 4f, 4h). The PicoGreen® data showed an increase on the number of BM-306 
MSCs over time. However, under osteogenic media, the cells presented lower 307 
proliferation rates than cultures under basal media from day 14. Noteworthy, is the 308 
prominent reduction of BM-MSCs for cultures with BBG-Mg (osteogenic and basal 309 
media) and 45S5 bioglass® (osteogenic media) at day 21. To emphasize, BBG-Sr and 310 
45S5 bioglass® under osteogenic media showed a significant reduction on the cell 311 
proliferation at day 14 when compared with the cells cultured under basal media, 312 
suggesting an alteration of biological behavior.(33) Regarding the effect of 313 
concentration, there was no potential toxic effects with time except in the case of BM-314 
MSCs cultured in the presence of BBG-Mg (osteogenic and basal media) and 45S5 315 
bioglass® (osteogenic media) at day 21, where a large reduction in cell number was 316 
observed in relation to the control (basal media). 317 
15 
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3.2.2 Alkaline phosphate quantification 318 
It is commonly accepted that ALP is a key player in the process of osteogenesis, being 319 
ALP known to be involved in early stages of normal and pathological calcification. (34-320 
36) In general, an increase of the ALP activity is correlated with osteogenesis, 321 
increasing during the bone formation stage.(37) Not surprisingly, the ALP 322 
quantification data (Figure 5) showed a significantly higher ALP activity when cells 323 
were cultured under osteogenic media rather than basal media.(38) However, at day 21 324 
the levels of ALP activity on BBG-Mg, -Sr and 45S5 bioglass® cultured under 325 
osteogenic media are significantly higher than the cultures without glass addition (e.g. 326 
at day 21, under osteogenic media, the addition of 20 mg of BBG-Sr (c) induced a 327 
highly significant (p<0.001) enhanced ALP activity in relation to the cells cultured in 328 
the absence of glass particles). BBG-Mg, -Sr and 45S5 bioglass® were not capable of 329 
inducing the ALP protein expression alone, however, they were capable to increase the 330 
ALP expression during the differentiation process of BM-MSCs into osteoblasts under 331 
osteogenic media (for 21 days of cell culture). It is relevant to point out that previous 332 
studies quantified the chemical species released from BBGs in solution, demonstrating a 333 
higher concentration of Mg2+ and Sr2+ ions (2-fold) when compared with Ca2+ (from 334 
BBG-Mg, BBGs-Sr and BBG-Ca, respectively). (29, 30) The presence of higher 335 
concentration of specific ions (i.e. Mg2+ and Sr2+) might facilitate cell differentiation. It 336 
is also relevant to highlight the fact that along with the increase of ALP activity for the 337 
case of BBG-Mg and -Sr glasses there was observed an increase of cell proliferation. In 338 
contrast, the viability and proliferation data, presented a reduction of viable and live 339 
cells for the BM-MSCs cultured in the presence of these BBG-Ca and 45S5 bioglass®. 340 
Remarkably, BBG-Sr promoted the increase of ALP activity for both concentrations of 341 
glass particles, i.e. 20 and 50 mg/ml. 342 
 16 
 343 
Figure 5. ALP activity of BM-MSCs (cultured either in basal or osteogenic media in 344 
the presence of different concentrations (0, 20 and 50 mg/ml) of BBG-Mg (a), BBG-Ca 345 
(b) and BBG-Sr (c). The 45S5 bioglass® (d) was used as control. Results are expressed 346 
as mean ± standard deviation with n = 3 for each bar. The data was analyzed by non-347 
parametric statistics: Kruskal-Wallis test (p IROORZHG E\ D 'XQQ¶V 0XOWLSOH348 
Comparison test. *** p<0.001; ** p<0.01; * p<0.05 in respect to the control. The 349 
statistical significance is represented relative to the control of BM-MSCs culture in 350 
basal media for the respective day of culture (i.e. 7, 14 and 21 days). 351 
 352 
3.2.3 Matrix mineralization 353 
Similar results were found at day 21 after alizarin red staining for mineral deposits 354 
(Figure 6). In agreement with ALP activity data, cells cultured under osteogenic media 355 
yielded more bone-like nodules, resulting from ECM mineralization.(35) The intense 356 
red spots dispersed in the cell culture correspond to the mineralized nodules. Of 357 
importance, and corroborating with ALP activity data, mineral deposits were more 358 
evident with BBG-Mg, -Sr and 45S5 bioglass® (Figure 6a, 6c and 6d) and an increase of 359 
red nodules with the increase of concentrations can be observed in the case of the cells 360 
cultured in the presence of BBG-Sr (Error! Reference source not found.c, osteo 20 361 
mg/ml and 50 mg/ml). Higher concentrations of BBG-Sr and 45S5 bioglass® show the 362 
presence of red nodules even in cells cultured in basal medium. However, ALP activity 363 
data, suggests that BBG-Sr and 45S5 bioglass® (Figure 6c and 6d basal for a 364 
concentration of 50 mg/ml) are capable to induce ECM mineralization by themselves. 365 
Therefore, the combination of ALP activity and mineralization results suggest the use of 366 
BBG-Sr to promote osteogenesis.(39) 367 
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 368 
Figure 6. Alizarin red staining of BM-MSCs cultured during 21 days, either in basal or 369 
osteogenic media in the presence of different concentrations (20 and 50 mg/ml) of 370 
BBG-Mg (a), BBG-Ca (b) and BBG-Sr (c). The 45S5 bioglass® (d) was used as control. 371 
 372 
Figure 7. SEM micrographs of BM-MSCs in the presence of different concentrations 373 
(20 and 50 mg/ml) of BBG-Mg (a), BBG-Ca (b) and BBG-Sr (c) after 21 days of cell 374 
culture either in basal or osteogenic media. Higher SEM magnifications are shown as 375 
insets, highlighting the formed apatite-like structures. The 45S5 bioglass® was used as a 376 
control. 377 
In Figure 7 we presented SEM micrographs of BM-MSCs cultured for 21 days in the 378 
presence of BBGs and 45S5 bioglass®. In the images it is possible to observe the 379 
deposition of minerals over the dense layer of cells, when they were cultured in the 380 
presence of BBG-Mg, -Sr and 45S5 bioglass® (Figure 7a, 7c and 7d). The presence of 381 
these glass compositions in the culture medium promoted a mineralization typical to 382 
occur while BM-MSCs differentiate into osteoblasts.(38) This mineralization is in 383 
agreement with the alizarin red data where the mineral deposits were more evident in 384 
the cells cultured in the presence of BBG-Mg, -Sr and 45S5 bioglass® (Figure 6a, 6c 385 
and 6d). In these culture conditions, it is observed in the SEM/EDS images calcium 386 
phosphate deposits over the dense cellular layer. Once more, higher concentrations of 387 
BBG-Sr and 45S5 bioglass® under basal culture conditions promoted the deposition of a 388 
higher amounts of calcium phosphate structures, suggesting that BBG-Sr and 45S5 389 
bioglass® (Figure 7c and 7d basal for a concentration of 50 mg/ml) are capable of 390 
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inducing ECM mineralization by itself, which could be beneficial for bone regeneration 391 
(39). 392 
3.2.4 Protein expression (OP and OC) 393 
Complementary to the reported biological data, the differentiation level of BM-MSC, 394 
cultured in the presence (20 and 50 mg/ml) and absence of BBG-Mg, -Ca, -Sr and 45S5 395 
bioglass® (either in basal or osteogenic media) was assessed by the quantification of the 396 
expression level of two major bone-specific proteins, i.e. OP and OC. The relative 397 
expression of these proteins was normalized in relation to the number of cells, i.e. 398 
amount of dsDNA. It is well known that osteoblasts are differentiated cells that 399 
mineralize the bone matrix. OP is a phosphoprotein synthesized by bone forming cells, 400 
which present calcium-binding domains and is responsible for cell attachment, 401 
proliferation, and ECM mineralization.(40) In the case of OC, it is a bone-specific 402 
glycoprotein capable of binding to calcium, which promotes ECM calcification.(40) Not 403 
surprisingly, the OP and OC quantification data (Figure 8 and Figure 9) showed a 404 
significantly higher protein expression when BM-MCSs were cultured under osteogenic 405 
media rather than basal media.(41) In the case of OP, as expected, a delay in the protein 406 
synthesis is observed (Figure 8). At day 7 there was no significant difference of OP 407 
expression in relation to the control (absence of glass particles and cell culture in basal 408 
medium). However, at day 14 there is a high expression peak by BM-MSCs cultured in 409 
osteogenic medium (in the presence of BBG-Mg, -Sr and 45S5 bioglass®), which 410 
determines the decay of the matrix deposition phase and the beginning of the 411 
mineralization phase. Moreover, BBG-Sr and 45S5 bioglass® continue to induce a 412 
significant overexpression of OP over time (e.g. at day 21), supporting the 413 
mineralization demonstrated by ALP and alizarin red analysis (Error! Reference 414 
source not found.Error! Reference source not found.Figure 5 and 6, respectively). In 415 
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the OC case there was a high protein expression up to day 14, indicating bone ECM 416 
maturation (Figure 9).(42) At day 7 there is a significant difference in OP expression in 417 
relation to the control (cell culture in basal medium and in the absence of glass 418 
particles). After day 7 there was a reduction of OC expression, consistent with matrix 419 
mineralization. Noteworthy is the observation that BBG-Sr under basal medium induced 420 
the BM-MSCs to exhibit a peak of OC expression at day 14. This data suggested that 421 
the BBG-Sr glass particles (at a concentration of 50 mg/ml) induced the OC protein 422 
expression, which is in agreement with the ALP and alizarin red data. Also, BBG-Sr 423 
and 45S5 bioglass® prolonged the OC overexpression over the 21 days of culture. In 424 
addition, the 45S5 bioglass® promoted a high deposition of OC at day 21 (Figure 4h) 425 
compared with high BM-MSCs density in the case of BBG-Sr (Figure 4f). However, it 426 
is important consider that in the case of the cultures in the presence of 45S5 bioglass® a 427 
very low BM-MSCs cell density was observed, which might be related with the 428 
cytotoxicity of 45S5 bioglass®.(43) Therefore, and overall our data suggests that the 429 
BBG-Sr glass particles are able to induce the BM-MSCs to express higher levels of OP 430 
and OC, while maintaining the BM-MSCs cell density. 431 
 432 
Figure 8. OP protein content of BM-MSCs cultured either with basal or osteogenic 433 
media in the presence of different concentrations (20 and 50 mg/ml) of BBG-Mg (a), 434 
BBG-Ca (b) and BBG-Sr (c). The 45S5 bioglass® (d) was used as control. Results are 435 
expressed as mean ± standard deviation with n = 3 for each bar. The data was analyzed 436 
by non-parametric statistics: Kruskal-Wallis test (p IROORZHG E\ D 'XQQ¶V437 
Multiple Comparison test. *** p<0.001; ** p<0.01; * p<0.05 in respect to the control. The 438 
statistical significance is represented relative to the control of BM-MSCs culture in 439 
basal media for the respective day of culture (i.e. 7, 14 and 21 days). 440 
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Figure 9. OC protein content of BM-MSCs cultured either with basal or osteogenic 443 
media in the presence of different concentrations (20 and 50 mg/ml) of BBG-Mg (a), 444 
BBG-Ca (b) and BBG-Sr (c). The 45S5 bioglass® (d) was used as control. Results are 445 
expressed as mean ± standard deviation with n = 3 for each bar. The data was analyzed 446 
by non-parametric statistics: Kruskal-Wallis test (p IROORZHG E\ D 'XQQ¶V447 
Multiple Comparison test. *** p<0.001; ** p<0.01; * p<0.05 in respect to the control. The 448 
statistical significance is represented relative to the control of BM-MSCs culture in 449 
basal media for the respective day of culture (i.e. 7, 14 and 21 days). 450 
 451 
Hence, combining the obtained biological data, i.e. viability, proliferation, 452 
mineralization and protein expression analysis (ALP, OC and OP), we were able to 453 
identify the BBG-Mg, -Sr (at concentrations of 20 to 50 mg/ml) as relevant promoters 454 
of the osteogenic differentiation of BM-MSCs. Several authors reported that Mg2+ ions 455 
significantly enhanced osteoblast adhesion by the altering cell-matrix interactions, 456 
which modulate the function of integrins related with cell differentiation. (19, 44) Our 457 
results suggest that BBG-Mg also promoted BM-MSCs differentiation, which might be 458 
related with the presence of Mg2+ in the culture medium. Remarkably, BBG-Sr (at a 459 
concentration of 50m/ml and 21 days of culture) presented the capacity to induce 460 
osteogenic response in BM-MSCs in the absence of osteogenic medium. Other authors 461 
reported Sr containing glasses to stimulate osteoblast metabolic activity, inhibiting 462 
osteoclast differentiation, as well as promoting the increment of ALP activity. (24) For 463 
instance, Hurtel-Lemaire et al. (45) have shown that Sr does induce osteoclast apoptosis 464 
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at concentrations higher than 9 mM. This is in accordance with our previous studies 465 
(29) that demonstrated a concentration of Sr in the reaction media about to 20 mM after 466 
3 days of culture. The ALP activity results showed the shift of BM-MSCs to a more 467 
differentiated state, while the alizarin red analysis demonstrated that the cells in the 468 
presence of BBG-Mg and BBG-Sr glass particles demonstrate intense and dispersed red 469 
spots in the cell culture, corresponding to the mineralization promoted by the BM-470 
MSCs. Santocildes et al. (25) demonstrated that the dissolution of Sr-containing glasses 471 
stimulated the upregulation of genes associated with the process of osteogenic 472 
differentiation, such as Bglap (osteocalcin) and Spp1 (osteopontin). In agreement with 473 
this data, we also observed that BBGs-Mg an BBG-Sr might also influence the ECM 474 
maturation and mineralization, through the promotion of the OP and OC protein 475 
overexpression, which suggests that these glass compositions may be effective in 476 
inducing and sustaining the osteoblastic phenotype. (46) 477 
4. Conclusion 478 
BBGs with different substituted divalent cations (Ca2+, Sr2+ or Mg2+) were successfully 479 
synthesized by melt quenching. In vitro studies demonstrated that the studied BBGs 480 
exhibit the capability to improve the osteogenic differentiation of BM-MSCs with no 481 
deleterious effects over cell viability and proliferation. Specially, BBG-Mg and BBG-Sr 482 
(at 20 and 50 mg/ml) provided favorable conditions for BM-MSCs to differentiate to 483 
osteoblast-like cells and induce the formation of a high amount of mineralized nodules. 484 
The phenotypic expression of two major bone-specific proteins, namely, OP and OC 485 
confirmed the osteogenic potential of the BBGs. 486 
Finally, the findings that the BBGs may promote in vitro cell differentiation into an 487 
osteogenic lineage, support their potential application in regenerative medicine. Based 488 
on these promising results we propose the incorporation of these BBGs into 489 
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biomaterials for bone regeneration. From our results, BBGs are able to enhance the 490 
osteogenic potential of the implants and promote the osteogenic differentiation of BM-491 
MSCs. The proposed BBGs are relevant candidates for further in vivo evaluation. 492 
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